NEON THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTUREIndenture • July 1st, 2019 • Neon Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of [•], among NEON THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • July 1st, 2019 • Neon Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Neon Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
